Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Samsung Electronics' investment arm is in discussions to join a group of firms backing software and medical device company ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

The first blood test used to diagnose Alzheimer’s disease was cleared by the Food and Drug Administration for marketing ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...

Psychiatry is on the brink of a precision medicine breakthrough. Discover how biomarkers and AI are transforming mental ...

Abbott boasts strong profitability, stable margins, and impressive long-term growth, but recent sales have stagnated. Check ...

The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...